Cargando…
Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations
BACKGROUND: Standard chemotherapy with taxanes, such as paclitaxel (PTX), remains the mainstay of systemic treatment of triple-negative breast cancer. Nanotechnology-based formulations have gradually replaced PTX injection and are widely used in China. However, no studies have compared the colloidal...
Autores principales: | Ye, Jun, Li, Renjie, Yang, Yanfang, Dong, Wujun, Wang, Yujie, Wang, Hongliang, Sun, Tong, Li, Lin, Shen, Qiqi, Qin, Caiyun, Xu, Xiaoyan, Liao, Hengfeng, Jin, Yiqun, Xia, Xuejun, Liu, Yuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256566/ https://www.ncbi.nlm.nih.gov/pubmed/34225762 http://dx.doi.org/10.1186/s12951-021-00946-w |
Ejemplares similares
-
Comparative Colloidal Stability of Commercial Amphotericin B Nanoformulations Using Dynamic and Static Multiple Light Scattering Techniques
por: Ye, Jun, et al.
Publicado: (2022) -
Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics
por: Ye, Jun, et al.
Publicado: (2022) -
Oral SMEDDS promotes lymphatic transport and mesenteric lymph nodes target of chlorogenic acid for effective T-cell antitumor immunity
por: Ye, Jun, et al.
Publicado: (2021) -
Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
por: Pei, Qing, et al.
Publicado: (2023) -
Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
por: Ye, Jun, et al.
Publicado: (2016)